Submission for OMB review; 30-day Comment Request;, 34360-34361 [2016-12726]

Download as PDF 34360 Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Allergy, Immunology, and Transplantation Research Committee. Date: June 22–23, 2016, Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 4H100 and 3C100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities/ Room 3G31B, National Institutes of Health, NIAID, 5601 Fishers Lane MSC 9834, Bethesda, MD 20892–9834, (240) 669–5060, james.snyder@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: June 27–29, 2016. Time: June 27, 2016, 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: Hilton Washington/Rockville, Jefferson Room, 1750 Rockville Pike, Rockville, MD 20852. Time: June 28, 2016, 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: Hilton Washington/Rockville, Jefferson Room, 1750 Rockville Pike, Rockville, MD 20852. Time: June 29, 2016, 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate contract proposals. Place: Hilton Washington/Rockville, Jefferson Room, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3F52B National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9834, Bethesda, MD 20892–9834, (240) 669–5044, nvazquez@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: May 24, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–12649 Filed 5–27–16; 8:45 am] amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel Development of a Biosensor-Based Core Needle Tumor Biopsy Device. Date: June 2, 2016. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove 9609 Medical Center Drive, Room 2W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Rockville, MD 20892–9750, 240–276–6373, bielatk@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS). Dated: May 24, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–12662 Filed 5–27–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P National Institutes of Health sradovich on DSK3TPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Submission for OMB review; 30-day Comment Request; National Institutes of Health Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research (OD) SUMMARY: In compliance with the requirement of Section 3507(a) (1) (D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Sep<11>2014 20:07 May 27, 2016 Jkt 238001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection instrument listed below. This proposed information collection was previously published in the Federal Register on March 25, 2016, page 16190 and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The NIH may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: Dr. Ellen Gadbois, Office of Science Policy, Office of the Director, NIH, Building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892, or call non-toll-free number (301) 496–9838 or Email your request, including your address to: gadboisel@ od.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: Request for Human Embryonic Stem Cell Line to be approved for Use in NIH Funded Research. OMB No. 0925–0601Expiration Date 5/31/2016—ExtensionOffice of Extramural Research (OER), National Institutes of Health (NIH). Need and Use of Information Collection: The form is used by applicants to request that human embryonic stem cell lines be approved for use in NIH funded research. Applicants may submit applications at any time. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 2,550. E:\FR\FM\31MYN1.SGM 31MYN1 34361 Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Number of respondents Number of responses per respondent Average time per response ( in hours) Total annual burden hour NIH grantees and others with hESC lines ....................................................... 50 3 17 2,550 Total .......................................................................................................... 50 150 ........................ 2,550 Dated: May 24, 2016. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2016–12726 Filed 5–27–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting sradovich on DSK3TPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Synthesis and Distribution of Opioid and Related Peptides (7795). Date: June 28, 2016. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892– 9550, (301) 435–1439, lf33c.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NonClinical ADME Studies (8931). Date: July 13, 2016. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive VerDate Sep<11>2014 20:07 May 27, 2016 Jkt 238001 Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892– 9550, (301) 435–1439, lf33c.nih.gov. (Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS). Dated: May 24, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–12647 Filed 5–27–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: CVRS New Investigator. Date: June 22, 2016. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Margaret Chandler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4126, MSC 7814, Bethesda, MD 20892, (301435– 1743, margaret.chandler@nih.gov. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Name of Committee: Interdisciplinary Molecular Sciences and Training Integrated Review Group; Enabling Bioanalytical and Imaging Technologies Study Section. Date: June 23–24, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115. Contact Person: Kenneth Ryan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3218, MSC 7717, Bethesda, MD 20892, 301–435– 0229, kenneth.ryan@nih.hhs.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group;Cancer Immunopathology and Immunotherapy Study Section. Date: June 23–24, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: The Embassy Row Hotel, 2015 Massachusetts Avenue NW., Washington, DC 20036. Contact Person: Denise R. Shaw, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD 20892, 301–435– 0198, shawdeni@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Review of Neuroscience AREA Grant Applications. Date: June 23–24, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: DoubleTree by Hilton, 1515 Rhode Island Avenue NW., Washington, DC 20005. Contact Person: Richard D. Crosland, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 20892, 301–435– 1220, crosland@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Biomedical Sensing, Measurement and Instrumentation. Date: June 24, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Inna Gorshkova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–435–1784, gorshkoi@csr.nih.gov. E:\FR\FM\31MYN1.SGM 31MYN1

Agencies

[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Pages 34360-34361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12726]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB review; 30-day Comment Request;

    Request for Human Embryonic Stem Cell Line To Be Approved for Use 
in NIH Funded Research (OD)
SUMMARY: In compliance with the requirement of Section 3507(a) (1) (D) 
of the Paperwork Reduction Act of 1995, the National Institutes of 
Health (NIH) has submitted to the Office of Management and Budget (OMB) 
a request for review and approval of the information collection 
instrument listed below. This proposed information collection was 
previously published in the Federal Register on March 25, 2016, page 
16190 and allowed 60-days for public comment. No public comments were 
received. The purpose of this notice is to allow an additional 30 days 
for public comment. The NIH may not conduct or sponsor, and the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project contact: Dr. Ellen Gadbois, Office of Science Policy, 
Office of the Director, NIH, Building 1, Room 218, MSC 0166, 9000 
Rockville Pike, Bethesda, MD 20892, or call non-toll-free number (301) 
496-9838 or Email your request, including your address to: 
gadboisel@od.nih.gov. Formal requests for additional plans and 
instruments must be requested in writing.
    Proposed Collection: Request for Human Embryonic Stem Cell Line to 
be approved for Use in NIH Funded Research. OMB No. 0925-0601- 
Expiration Date 5/31/2016--Extension- Office of Extramural Research 
(OER), National Institutes of Health (NIH).
    Need and Use of Information Collection: The form is used by 
applicants to request that human embryonic stem cell lines be approved 
for use in NIH funded research. Applicants may submit applications at 
any time.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 2,550.

[[Page 34361]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per  per response (   Total annual
                                                    respondents     respondent       in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
NIH grantees and others with hESC lines.........              50               3              17           2,550
                                                 ---------------------------------------------------------------
    Total.......................................              50             150  ..............           2,550
----------------------------------------------------------------------------------------------------------------


    Dated: May 24, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016-12726 Filed 5-27-16; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.